CooperCompanies | Sustainability Performance
Cooper Companies develops and markets medical devices and health products, specializing in ophthalmic care and women's health. Its key offerings include contact lenses and reproductive health solutions. The company focuses on advancing healthcare through innovation, improving patient outcomes, and expanding access to its products globally.
1958
United States
10,001+ employees
Medical Device
$1B - 10B in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#7592
Overall#1623
in United States#118
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Environmental
Carbon emissionsEnergy consumptionGovernance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
CO2 scope 1 + 2
Laggard
Renewable energy
Laggard
Market cap
Revenue
R&D intensity
Carbon emissions
Reveal data for 1 credit
Industry rank: 43 out of 175
Total CO2 emissions
(CO2e tonnes)
Industry rank: 43 out of 175
Scope 1
Scope 2 location based
Scope 3 downstream
Scope 3 upstream
Industry benchmark
(adj. for revenues)
(adj. for revenues)
Renewable energy
Reveal data for 1 credit
17%2024
Industry rank: 33 out of 175
Total energy consumption
and % renewables
(MWh, % of consumption)
Industry rank: 33 out of 175
Total energy
Share of renewable energy
Industry benchmark
Renewable electricity
Reveal data for 1 credit
Industry rank: Beyond Top 100
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: Beyond Top 100
Total electricity
Share of renewable electricity
Industry benchmark
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Industry Benchmark
21.6
B/M 12.7
117.0
B/M 24.0
Powered by illuminem and GIST Impact
Controversy level
- The Cooper Companies Inc (CooperVision, CooperSurgical), US major contact lenses/women's health medical devices, has faced multiple US class actions over alleged inadequate disclosure of US/European contact lens customer demand normalization following the contested 2024 sustained share price volatility amid US discretionary contact lens customer demand normalization affecting US institutional shareholders amid US medical device sector normalization pressure.
Carbon emissions breakdown
Reveal data for 2 credits
| KPI | Metric | Year | |||||
|---|---|---|---|---|---|---|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | Benchmark | ||
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$4.1BFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Revenue by region
Revenue by region %
Europe
Rest of World
United States
Powered by illuminem
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
4.2%FY2025
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
3.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
3.6
▲ 0.1%
3.9
▼ 0.2%
4.1
▲ 0.1%
5.3
2030Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Available
Recycling policy
Not available
Workplace health & safety policy
Available
47%
Independent Directors
7 out of 15 incl. management
Overall score
63
Environment
55
Social
65
Governance
69
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
